Capital Investment Advisory Services LLC lessened its position in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 22.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,525 shares of the company’s stock after selling 2,425 shares during the quarter. Capital Investment […]
Moore Capital Management LP bought a new position in Legend Biotech Co. (NASDAQ:LEGN – Get Rating) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 10,000 shares of the company’s stock, valued at approximately $499,000. Other large investors also recently added to or reduced their […]
Legend Biotech Co. (NASDAQ:LEGN – Get Rating) – Analysts at HC Wainwright lifted their Q2 2023 earnings estimates for Legend Biotech in a research report issued to clients and investors on Tuesday, June 6th. HC Wainwright analyst M. Kapoor now expects that the company will earn ($0.34) per share for the quarter, up from their […]
TimesSquare Capital Management LLC grew its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Get Rating) by 0.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 946,500 shares of the company’s stock after buying an additional 5,200 shares during the quarter. […]
Matthews International Capital Management LLC lowered its position in Legend Biotech Co. (NASDAQ:LEGN – Get Rating) by 20.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,171,768 shares of the company’s stock after selling 294,685 shares during the quarter. Legend Biotech accounts for […]